Markets
Stocks
Mutual Funds & ETF's
Sectors
Tools
Overview
Market News
Currencies
International
Search InvestCenter
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Top Indices
DJI
Nasdaq Composite
SPX
My Portfolio
Altimmune Inc
(NQ:
ALT
)
6.550
UNCHANGED
Streaming Delayed Price
Updated: 4:00 PM EDT, Jul 18, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Price and Volume
Detailed Quote
Volume
2,062
Open
6.550
Bid (Size)
6.570 (1)
Ask (Size)
6.650 (10)
Prev. Close
6.550
Today's Range
6.550 - 6.550
52wk Range
2.090 - 14.84
Shares Outstanding
70,902,191
Dividend Yield
N/A
Intraday
1 Week
1 Month
3 Month
1 Year
3 Year
5 Year
Top News
More News
3 Undervalued Biotech Stocks With Breakout Potential
Today 6:00 EDT
Invest in these three undervalued biotech stocks with double-digit upside ahead driven by cutting-edge healthcare advancements
Via
InvestorPlace
Forget Boring Diversification! 3 Wild-Card Stocks to Spice Up Your Portfolio
July 17, 2024
These three wild-card stocks will spice up your portfolio in ways boring diversification never could, so read on.
Via
InvestorPlace
Performance
YTD
-37.74%
-37.74%
1 Month
+10.83%
+10.83%
3 Month
-4.93%
-4.93%
6 Month
-39.30%
-39.30%
1 Year
+104.69%
+104.69%
More News
Read More
Better GLP-1 Biotech Stock: Altimmune vs. Viking Therapeutics
July 10, 2024
Via
The Motley Fool
Eli Lilly Stock Leads in GLP-1 Race with its Triple Agonist Drug
July 09, 2024
Via
MarketBeat
7 Bullish Stock Picks With the Potential to Turn $5K Into $50K
July 09, 2024
Via
InvestorPlace
The 7 Best Under $10 Stocks to Buy in July 2024
July 06, 2024
Via
InvestorPlace
MarketBeat Week in Review – 7/1 - 7/5
July 06, 2024
Via
MarketBeat
Topics
Economy
Exposures
Interest Rates
Bragar Eagel & Squire, P.C. Reminds Investors That Class Action Lawsuits Have Been Filed Against Intel, Harbor Diversified, Altimmune, and Sprout Social and Encourages Investors to Contact the Firm
July 04, 2024
From
Bragar Eagel & Squire
Via
GlobeNewswire
SHAREHOLDER NOTICE: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Altimmune
July 04, 2024
From
Faruqi & Faruqi LLP
Via
GlobeNewswire
ALTIMMUNE DEADLINE ALERT: Bragar Eagel & Squire, P.C. Reminds Investors that a Class Action Lawsuit Has Been Filed Against Altimmune, Inc. and Encourages Investors to Contact the Firm
July 03, 2024
From
Bragar Eagel & Squire
Via
GlobeNewswire
The Law Offices of Frank R. Cruz Reminds Investors of Looming Deadline in the Class Action Lawsuit Against Altimmune, Inc. (ALT)
July 03, 2024
From
Law Offices of Frank R. Cruz
Via
Business Wire
Altimmune Stock: Is Its GLP-1 Drug the Next Ozempic Killer?
July 03, 2024
Via
MarketBeat
Exposures
Product Safety
Pfizer Stock is Ready to Stage a Turnaround on GLP-1 Hopes
July 02, 2024
Via
MarketBeat
Eli Lilly Stock Up: GLP-1 Zepbound Targets Sleep Apnea Market
July 01, 2024
Via
MarketBeat
Exposures
Product Safety
ALTIMMUNE, INC. (NASDAQ: ALT) DEADLINE ALERT: Bernstein Liebhard LLP Reminds Altimmune, Inc. Investors of Upcoming Deadline
July 01, 2024
From
Bernstein Liebhard LLP
Via
GlobeNewswire
Bragar Eagel & Squire, P.C. Reminds Investors That Class Action Lawsuits Have Been Filed Against Intel, AXT, Harbor Diversified, and Altimmune and Encourages Investors to Contact the Firm
June 30, 2024
From
Bragar Eagel & Squire
Via
GlobeNewswire
3 Reasons Why Altimmune Stock Could Be the Next Viking Therapeutics
June 30, 2024
Via
The Motley Fool
If These 3 Words Are True, Altimmune's Weight Loss Candidate Could Beat Novo Nordisk's Wegovy
June 29, 2024
Via
The Motley Fool
Lowey Dannenberg Notifies Altimmune, Inc. (“Altimmune” or the “Company”) (NASDAQ: ALT) Investors of Securities Class Action Lawsuit and Encourages Investors with more than $100,000 in Losses to Contact the Firm
June 28, 2024
From
Lowey Dannenberg, P.C.
Via
GlobeNewswire
The 3 Smartest Biotech Stocks to Buy With $5K Right Now
June 28, 2024
Via
InvestorPlace
ONGOING DEADLINE ALERT: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Altimmune
June 28, 2024
From
Faruqi & Faruqi LLP
Via
GlobeNewswire
Why Are Altimmune Shares Trading Lower Wednesday?
June 26, 2024
Via
Benzinga
Bragar Eagel & Squire, P.C. Reminds Investors That Class Action Lawsuits Have Been Filed Against Harbor Diversified, Altimmune, Sprout Social, and Inari and Encourages Investors to Contact the Firm
June 25, 2024
From
Bragar Eagel & Squire
Via
GlobeNewswire
ALTIMMUNE, INC. (NASDAQ: ALT) DEADLINE ALERT: Bernstein Liebhard LLP Reminds Altimmune, Inc. Investors of Upcoming Deadline
June 24, 2024
From
Bernstein Liebhard LLP
Via
GlobeNewswire
Lowey Dannenberg Notifies Altimmune, Inc. (“Altimmune” or the “Company”) (NASDAQ: ALT) Investors of Securities Class Action Lawsuit and Encourages Investors with more than $100,000 in Losses to Contact the Firm
June 24, 2024
From
Lowey Dannenberg, P.C.
Via
GlobeNewswire
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.